dc.contributor.author |
Varma, S S |
|
dc.contributor.author |
Aiswarya, S U |
|
dc.contributor.author |
Keerthana, C K |
|
dc.contributor.author |
Rayginia, T P |
|
dc.contributor.author |
Induja, D K |
|
dc.contributor.author |
Anto, R J |
|
dc.contributor.author |
Lankalapalli, R S |
|
dc.date.accessioned |
2023-11-04T12:06:02Z |
|
dc.date.available |
2023-11-04T12:06:02Z |
|
dc.date.issued |
2023-09-01 |
|
dc.identifier.citation |
Tetrahedron Letters; 127:154668 |
en_US |
dc.identifier.uri |
https://www.sciencedirect.com/science/article/pii/S0040403923003787?via%3Dihub |
|
dc.identifier.uri |
http://localhost:8080/xmlui/handle/123456789/4576 |
|
dc.description.abstract |
Uttroside B from Solanum nigrum Linn. exhibited potent cytotoxicity against HepG2 cells with an IC50 of 0.5 μM; interestingly, its congeners uttroside A and uttronin exhibited the same level of activity. We hypothesized that spirocyclization is the critical step for the activity of uttroside A or B that results in the formation of uttronin. To support our hypothesis, an uttroside B analogue was synthesized that cannot undergo spirocyclization, which resulted in a loss of cytotoxic activity. Mass spectral analysis of the supernatant from the cells treated with uttroside B further supported the spirocyclization of uttroside B to uttronin. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Elsevier |
en_US |
dc.subject |
solanum nigrum |
en_US |
dc.subject |
uttroside B |
en_US |
dc.subject |
uttronin |
en_US |
dc.subject |
degalactotigonin |
en_US |
dc.subject |
spirocyclization |
en_US |
dc.subject |
prodrug |
en_US |
dc.title |
Putative role of uttronin (degalactotigonin) in cytotoxicity of uttroside B in HepG2 cells |
en_US |
dc.type |
Article |
en_US |